A pilot study identifying statin nonadherence with visit-to-visit variability of low-density lipoprotein cholesterol

American Journal of Cardiology

Volumn 111, Issue 10, 2013, Pages 1437-1442

  Mann, Devin M ^a   Glazer, Nicole L ^a,b   Winter, Michael ^c   Paasche Orlow, Michael K ^a   Muntner, Paul ^d   Shimbo, Daichi ^e   Adams, William G ^a   Kressin, Nancy R ^a,f   Zhang, Yuqing ^a   Choi, Hyon ^a   Cabral, Howard ^c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON UNIVERSITY   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e Department of Medicine   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; FEMALE; HEALTH CENTER; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PATIENT COMPLIANCE; PHARMACY; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; VISIT TO VISIT VARIABILITY;

BOSTON; CHOLESTEROL, LDL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MEDICATION ADHERENCE; MIDDLE AGED; ODDS RATIO; OFFICE VISITS; PILOT PROJECTS; RETROSPECTIVE STUDIES;

EID: 84877001008     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.01.297     Document Type: Article

References (17)

1. R. Clarke, M. Shipley, S. Lewington, L. Youngman, R. Collins, M. Marmot, and R. Peto Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies Am J Epidemiol 150 1999 341 353
2. S. MacMahon, R. Peto, J. Cutler, R. Collins, P. Sorlie, J. Neaton, R. Abbott, J. Godwin, A. Dyer, and J. Stamler Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias Lancet 335 1990 765 774
3. S.S. Gidding, N.J. Stone, L.C. Bookstein, P.M. Laskarzewski, and E.A. Stein Month-to-month variability of lipids, lipoproteins, and apolipoproteins and the impact of acute infection in adolescents J Pediatr 133 1998 242 246
4. P.P. Glasziou, L. Irwig, S. Heritier, R.J. Simes, and A. Tonkin Monitoring cholesterol levels: measurement error or true change? Ann Intern Med 148 2008 656 661
5. A.J. Webb, U. Fischer, Z. Mehta, and P.M. Rothwell Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis Lancet 375 2010 906 915
6. P. Muntner, D. Shimbo, M. Tonelli, K. Reynolds, D.K. Arnett, and S. Oparil The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994 Hypertension 57 2011 160 166
7. J.F. Steiner, and A.V. Prochazka The assessment of refill compliance using pharmacy records: methods, validity, and applications J Clin Epidemiol 50 1997 105 116
8. L. Osterberg, and T. Blaschke Adherence to medication N Engl J Med 353 2005 487 497
9. D.M. Mann, M. Woodward, P. Muntner, L. Falzon, and I. Kronish Predictors of nonadherence to statins: a systematic review and meta-analysis Ann Pharmacother 44 2010 1410 1421
10. P.A. Caetano, J.M.C. Lam, and S.G. Morgan Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization Clin Ther 28 2006 1411 1424
11. A.K. Jha, T.G. Ferris, K. Donelan, C. DesRoches, A. Shields, S. Rosenbaum, and D. Blumenthal How common are electronic health records in the United States? A summary of the evidence Health Aff (Millwood) 25 2006 w496 w507
12. J.F. Steiner, P.M. Ho, B.L. Beaty, L.M. Dickinson, R. Hanratty, C. Zeng, H.M. Tavel, E.P. Havranek, A.J. Davidson, D.J. Magid, and R.O. Estacio Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension Circ Cardiovasc Qual Outcomes 2 2009 451 457
13. D.M. Mann, J.P. Allegrante, S. Natarajan, E.A. Halm, and M. Charlson Predictors of adherence to statins for primary prevention Cardiovasc Drugs Ther 21 2007 311 316
14. J.J. Ellis, S.R. Erickson, J.G. Stevenson, S.J. Bernstein, R.A. Stiles, and A.M. Fendrick Suboptimal statin adherence and discontinuation in primary and secondary prevention populations: should we target patients with the most to gain? J Gen Intern Med 19 2004 638 645
15. D. Mann Resistant disease or resistant patient: problems with adherence to cardiovascular medications in the elderly? Geriatrics 4 2009 10 15
16. J.K. Lee, K.A. Grace, and A.J. Taylor Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial JAMA 296 2006 2563 2571
17. S. Kanjilal, E.W. Gregg, Y.J. Cheng, P. Zhang, D.E. Nelson, G. Mensah, and G.L.A. Beckles Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002 Arch Intern Med 166 2006 2348 2355